10 years ago, under the vision of James N'Dow, we set out to bring #EAUGuidelines to #socialmedia . It started with a small group, driven by the belief that guidelines become truly valuable when they are shared, discussed, and used together. Leading that first Dissemination

U.S. FDA approves durvalumab for perioperative immunotherapy for patients with muscle-invasive bladder cancer In a prespecified analysis, the trial demonstrated a statistically significant improvement in event-free survival and overall survival. American Cancer Society Suresh S. Ramalingam, MD, FASCO

🌟Challenges in Defining Clinical CR to Systemic Therapy in MIBC🌟 EORTC #STARBURST project 🖋️ Alexandra Masson-Lecomte @AFUrology, Guillaume Grisay, Julien Van Damme,  Vérane Achard  , Laura S. Mertens, Robert Huddart💙, francesco soria, Lars Dyrskjøt, Yves Allory Institut Curie,

💫🌟🎯 Long-term surveillance in young adult cancer survivors 📌 Egger-Heidrich et al. | Cancer Treatment Reviews, 2025 💥 “Survival is not enough — thriving requires tailored follow-up.” Cancers MDPI OncoAlert 🔎 Key insights: ✔️YACS face unique risks: SMN, cardiotoxicity,

🎓 Nova Càtedra UB BCLC per impulsar el coneixement i la prevenció del #càncer de fetge 🔬 Neix amb l’objectiu de traslladar a la societat els coneixements actuals de la malaltia i presentar els reptes que hi ha per millorar-ne l’atenció, la innovació i la #investigació ➕ Info

Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to Stephen Freedland, MD neal shore & team! Earlier enza works better! Link👉 rb.gy/iyc3f2 OncoAlert UroToday.com Prostate Cancer Foundation

🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘 🔍 Covering: ✅ State-of-the-art imaging (US, low-dose CT) ✅ MET, ESWL, URS, PCNL ✅ Genetic testing in high-risk patients ✅ Personalized treatment pathways ✅ Practical

Gisele Pelicot awarded France's Legion of Honour - BBC News Absolutely deserved..! bbc.com/news/articles/…

Felicitats a la Dra. Maria Reig Maria Reig per liderar una iniciativa clau des del coneixement, la visió i el compromís. Reconeixement, lideratge clínic i mirada estratègica són més necessaris que mai per construir el futur que volem. Orgullosa de compartir camí amb companyes que

Just came online in The Lancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh Prostate Cancer Foundation UroToday.com OncoAlert

Feet on the desk!! ( such a long time now…🧐🧐) it’s that time again ☀️ Time to unplug, reconnect with nature and (hopefully) recharge. Wishing you all a peaceful summer off!! And 🙏🏻🙏🏻🙏🏻. may the second half of the year be gentler, brighter, and full of purpose. #SummerBreak

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

Strong Andrology girl power publication w amazing @UCLH team … rdcu.be/exM9W Patient satisfaction in priapism patients with penile implants, excellent article to help counsel patients in a difficult setting Izzie Dighero Aisling Looney Chloe Mount Fiona Holden